Was that margin in line w your expectation? It’s nowhere close to the margin of “premium” vaccines like prevnar, gardasil, shingrix, etc. Given the much lower price point compared to those vaccines not all that surprising I guess. I just had no idea of COG for this kind of vaccine. I don’t own PFE and never bothered to hazard a guess but off the cuff I would have thought margin would be higher frankly. I wonder how much the cold chain requirements eat into the margin and how much profit they could squeeze out w a lyophilized version